Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026 Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases Galapagos Announces Nomination of Gino Santini to its Board of Directors Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases Galapagos Receives Transparency Notification from Bank of America Galapagos Receives Transparency Notifications from Bank of America   Galapagos Creates New Subscription Right Plan Galapagos Appoints Tania Philipp as Chief Human Resources Officer Galapagos Receives Transparency Notifications from Bank of America Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors   Galapagos Receives Transparency Notification from Bank of America Galapagos Receives Transparency Notifications from Bank of America